Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436979 · ClinicalTrials.gov registry record
The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse
A clinical trial of Uterine Prolapse Without Vaginal Wall Prolapse, sponsored by Pop Medical Solutions.
- Completed
- Registry status
- 60
- Enrollment target
- 15
- Study locations
NCT03436979 is a study of Uterine Prolapse Without Vaginal Wall Prolapse that has completed, run by Pop Medical Solutions. The registered enrollment target is 60 participants. The trial reports 15 study locations across 9 states.
The verdict
NCT03436979, a study of Uterine Prolapse Without Vaginal Wall Prolapse, has completed, sponsored by Pop Medical Solutions.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.
Conditions Studied
Interventions
- DEVICE NeuGuide™ System
Study Locations (15)
Other
- Krankenhaus Waldfriede - Berlin-Zehlendorf
- Isar Kliniken GmbH - München
- St. Joseph Krankenhaus - Tempelhof
- Soroka Medical Center - Beersheba
Florida
- Holy Cross Hospital - Fort Lauderdale
- Cleveland Clinic Florida - Weston
New York
- Maimonides Medical Center - Brooklyn
- South Nassau Community Hospital Cancer Center - Valley Stream
Pennsylvania
- The Institute for Female Pelvic Medicine and Reconstructive Surgery - Allentown
- Female Pelvic Health Center - Newtown
District of Columbia
- MedStar Health Research Institute - Washington D.C.
Massachusetts
- Mount Auburn Hospital - Cambridge
Ohio
- Cleveland Clinic Cleveland - Cleveland
Texas
- Walnut Hill OB/GYN Associates - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2023-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03436979
The ClinicalTrials.gov registry entry for NCT03436979 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pop Medical Solutions, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Prolapse Without Vaginal Wall Prolapse appearing as the primary indexed condition, and to 1 intervention - of which NeuGuide™ System is the first listed.
NCT03436979 reports 15 study locations spanning 9 distinct geographic areas - top geographies include Other, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT03436979 about?
NCT03436979 is a clinical study titled "The NeuGuide™ System for Vaginal Colpopexy in the Treatment of Uterine Prolapse". The objective of the study is to assess the long term safety, durability of clinical effectiveness and cost effectiveness of the NeuGuide™ system when used for vaginal colpopexy in the treatment of uterine prolapse.
What is the current status of trial NCT03436979?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-01-01. Estimated completion is 2023-10-31.
What conditions does trial NCT03436979 study?
This clinical trial studies the following conditions: Uterine Prolapse Without Vaginal Wall Prolapse.
What interventions are being tested in trial NCT03436979?
The interventions under investigation include: NeuGuide™ System (DEVICE).
Who is sponsoring clinical trial NCT03436979?
This trial is sponsored by Pop Medical Solutions, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03436979 being conducted?
This trial has 15 study locations across District of Columbia, Florida, Massachusetts, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.